- United States
- /
- Healthcare Services
- /
- OTCPK:NVTA.Q
Invitae Corporation's (NYSE:NVTA)) market cap declines to US$3.4b but insiders who sold US$13m stock were able to hedge their losses
By selling US$13m worth of Invitae Corporation (NYSE:NVTA) stock at an average sell price of US$37.41 over the last year, insiders seemed to have made the most of their holdings. The company's market worth decreased by US$679m over the past week after the stock price dropped 17%, although insiders were able to minimize their losses
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Invitae
The Last 12 Months Of Insider Transactions At Invitae
Over the last year, we can see that the biggest insider sale was by the insider, Jason Myers, for US$3.4m worth of shares, at about US$47.32 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$14.99. So it may not tell us anything about how insiders feel about the current share price.
Invitae insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Does Invitae Boast High Insider Ownership?
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Invitae insiders own about US$22m worth of shares. That equates to 0.6% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
What Might The Insider Transactions At Invitae Tell Us?
The fact that there have been no Invitae insider transactions recently certainly doesn't bother us. Our analysis of Invitae insider transactions leaves us cautious. The modest level of insider ownership is, at least, some comfort. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To that end, you should learn about the 4 warning signs we've spotted with Invitae (including 1 which is significant).
Of course Invitae may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OTCPK:NVTA.Q
Invitae
A medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally.
Medium-low and slightly overvalued.